Brief: Abionyx Pharma Manufactures Third Batch Of Recombinant Human ApoA-I CER-001 With New Industrial Bioprocess

Abionyx Pharma SA

18/12/2023 17:02

Dec 18 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX PHARMA SUCCESSFULLY MANUFACTURES A THIRD BATCH OF
RECOMBINANT HUMAN APOA-I CER-001 USING A NEW, INNOVATIVE AND
ROBUST INDUSTRIAL BIOPROCESS
    * PREPARATION OF BIOMANUFACTURING REQUIRING 3 CONSECUTIVE
BATCHES
FOR MARKETING AUTHORIZATION
    * AS INDICATED LAST OCTOBER AT TIME OF CAPITAL INCREASE,
COMPANY'S
FINANCIAL VISIBILITY IS NOW EXTENDED TO Q1 2025, WITHOUT DRAWING
ON EQUITY-LINKED FINANCING FACILITY

Source text for Eikon:  ID:nBw71k2Ka 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))